|
Interaction between pharmacists and the National Institute for Clinical Excellence is critical for the success of the institute.
|
![]() At the House of Commons (left to Right) Howard Stoate, MP (chairman, APD), Jenny Tongue, MP (vice chairman, APG) Veronica Wray (head of public affairs, National Pharmaceutical Association) and Sir Micheal |
Sir Michael added that the profession had a major role in the development and implementation of clinical audit and in the implementation of NICE guidelines. It also had a potentially important role in the production, dissemination and implementation of information for patients and the public.
The NICE would produce guidelines that were directed towards pharmacy practice. It was necessary to encourage extension of the role of pharmacists, particularly community pharmacists, in initiating treatment, such as emergency hormonal contraception, and in monitoring treatment, such as anticoagulation.
Other ways in which Sir Michael said pharmacists could help achieve clinical excellence included helping other health professionals use medicines more effectively and enabling patients to manage their illnesses better. In this regard, he said that pharmacists should welcome P-to-GSL changes and not throw up their hands in horror. Such changes were in the interest of consumers and enabled them to take a hand in their own treatment.